Targeted therapies in oncology: where we are and what lies ahead
This is my first popular science piece to have found a place in a biotech magazine: Asia-Pacific Biotech News (APBN February 2017 issue). The article starts off with the challenges with traditional cancer therapies that has led to the evolution of targeted therepies, what has been achieved in different avenues here; it concludes with a short note on what could be expected in the coming decade (Precision medicine).
The audience mainly comprises of university researchers/students, industry scientists, and public, so the scope of the article is rather broad. The link to my article on APBN website is as follows:
No comments:
Post a Comment